The global optical genome mapping market size was estimated at USD 173 million in 2024 and is projected to be worth around USD 1439.56 million by 2034, growing at a CAGR of 23.6%.
The optical genome mapping market is an integral branch of the healthcare industry. This industry deals in developing imaging techniques used for analyzing the structural variants of a genome. There are several products manufactured in this industry comprising of instruments, consumables & reagents, software and services. The growing demand for precision medicine to treat rare-diseases such as Acanthocytosis Chorea and Duchenne muscular dystrophy (DMD) has driven the market growth. This market is expected to rise significantly with the growth of the biotechnology industry across the globe.
The growing prevalence of genetic disorders such as sickle cell anemia, down’s syndrome, Angelman syndrome, albinism, and some others has boosted the market growth. Also, numerous government investments in genomics research coupled with the rapid adoption of targeted therapies are shaping the industry in a positive direction. Moreover, the increased application of genome mapping technology for genome assembly, microbial strain typing, structural variant detection, and some others, along with increasing demand for this mapping technology from several end-users such as biotechnology and pharmaceutical companies, clinical laboratories, academic research institutes, and some others is anticipated to propel the growth of the optical genome mapping market. The developments in cytogenetic methodologies along with rapid advancements in sequencing technologies are expected to create ample growth opportunities for the market players in the upcoming days
Published by Ajit Bansod
